ResMed to Report Second Quarter Fiscal 2019 Earnings on January 24, 2019

SAN DIEGO, January 3, 2019 ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.              

Earnings webcast details:

  • Location:         http://investor.resmed.com
  • Date:               Thursday, January 24, 2019
  • Time:               1:30 p.m. PT / 4:30 p.m. ET
  • International:   
    • London, Thursday, January 24, 9:30 p.m.
    • Sydney, Friday, January 25, 8:30 a.m.

Please note that ResMed does not use outside phone lines to access the earnings call.

A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from January 24 until February 7 at:

  • U.S.: +1 800.585.8367
  • International: +1 416.621.4642
  • Passcode: 6179558

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

# # #

MEDIA: Jayme Rubenstein, 858.836.6798, news@resmed.com | INVESTORS: Amy Wakeham, 858.836.5000, investorrelations@resmed.com
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages